.Sanofi has quit a phase 2 hardship of Denali Therapeutics-partnered oditrasertib in several scleros...
.Turnstone Biologics is lowering its own headcount through 60% and also shocking its C-suite so as t...
.In a year that has observed an approval as well as a plethora of readouts for metabolic dysfunction...
.Alaunos Rehabs is axing an agreement along with Precigen, losing hope licensing civil liberties to ...
.Capricor Therapeutics is taking a triumph lap for their phase 2 Duchenne muscle dystrophy (DMD) tri...
.The FDA has positioned Kezar Life Sciences' lupus test on hold after the biotech flagged four death...
.A phase 3 trial of Academic Rock's back muscle degeneration (SMA) applicant has actually struck its...
.RNA biotech CAMP4 Therapeutics has marked out prepare for a $67 million IPO, with inflammation-focu...
.A year after the failing of an idiopathic pulmonary fibrosis candidate delivered Galecto on a seek ...
.Taking the floor covering is Judo Bio, an ambitious biotech armed along with $one hundred million t...